Previously, Cheng et al. (31) found that EZH2 promotes CRC stem-like cell expansion by activating p21 cip1 -Wnt/β-catenin signaling, supporting the hypothesis that EZH2 may serve as a novel CSC marker and a potential target for cancer therapy. Here, EZH2 is linked to colorectal carcinoma.